| Bioengineered silk protein-based gene delivery systems K Numata, B Subramanian, HA Currie, DL Kaplan Biomaterials 30 (29), 5775-5784, 2009 | 153 | 2009 |
| Tissue-Engineered Three-Dimensional In Vitro Models for Normal and Diseased Kidney B Subramanian, D Rudym, C Cannizzaro, R Perrone, J Zhou, DL Kaplan Tissue Engineering Part A 16 (9), 2821-2831, 2010 | 136 | 2010 |
| Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs K Numata, J Hamasaki, B Subramanian, DL Kaplan Journal of controlled release 146 (1), 136-143, 2010 | 118 | 2010 |
| Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties F Kuo, B Subramanian, T Kotyla, TA Wilson, S Yoganathan, RJ Nicolosi International journal of pharmaceutics 363 (1-2), 206-213, 2008 | 103 | 2008 |
| Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity J Chun, JY Zhang, MS Wilkins, B Subramanian, C Riella, JM Magraner, ... Proceedings of the National Academy of Sciences 116 (9), 3712-3721, 2019 | 76 | 2019 |
| Enhancement of anti-inflammatory property of aspirin in mice by a nano-emulsion preparation B Subramanian, F Kuo, E Ada, T Kotyla, T Wilson, S Yoganathan, ... International immunopharmacology 8 (11), 1533-1539, 2008 | 67 | 2008 |
| Development of an in vitro model to study the impact of BMP‐2 on metastasis to bone H Kwon, HJ Kim, WL Rice, B Subramanian, SH Park, I Georgakoudi, ... Journal of tissue engineering and regenerative medicine 4 (8), 590-599, 2010 | 56 | 2010 |
| Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury B Subramanian, H Sun, P Yan, VT Charoonratana, HN Higgs, F Wang, ... Kidney international 90 (2), 363-372, 2016 | 47 | 2016 |
| Preadipocytes stimulate ductal morphogenesis and functional differentiation of human mammary epithelial cells on 3D silk scaffolds X Wang, X Zhang, L Sun, B Subramanian, MV Maffini, A Soto, ... Tissue Engineering Part A 15 (10), 3087-3098, 2009 | 45 | 2009 |
| Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease GM McCarthy, A Blasio, OG Donovan, LB Schaller, A Bock-Hughes, ... Disease Models & Mechanisms 14 (8), dmm048952, 2021 | 42 | 2021 |
| The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions B Subramanian, WC Ko, V Yadav, TM DesRochers, RD Perrone, J Zhou, ... Biomaterials 33 (33), 8383-8394, 2012 | 35 | 2012 |
| Cell‐tethered ligands modulate bone remodeling by osteoblasts and osteoclasts RS Hayden, JP Fortin, B Harwood, B Subramanian, KP Quinn, ... Advanced functional materials 24 (4), 472-479, 2014 | 26 | 2014 |
| Dysregulated dynein-mediated trafficking of nephrin causes INF2-related podocytopathy H Sun, C Perez-Gill, JS Schlöndorff, B Subramanian, MR Pollak Journal of the American Society of Nephrology 32 (2), 307-322, 2021 | 22 | 2021 |
| FSGS-causing INF2 mutation impairs cleaved INF2 N-fragment functions in podocytes B Subramanian, J Chun, C Perez-Gill, P Yan, IE Stillman, HN Higgs, ... Journal of the American Society of Nephrology 31 (2), 374-391, 2020 | 19 | 2020 |
| Loss of Raf-1 kinase inhibitory protein delays early-onset severe retinal ciliopathy in Cep290rd16 mouse B Subramanian, M Anand, NW Khan, H Khanna Investigative ophthalmology & visual science 55 (9), 5788-5794, 2014 | 19 | 2014 |
| ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit CV Riella, M McNulty, GT Ribas, CF Tattersfield, C Perez-Gill, F Eichinger, ... Proceedings of the National Academy of Sciences 119 (44), e2210150119, 2022 | 13 | 2022 |
| Guided tissue organization and disease modeling in a kidney tubule array B Subramanian, O Kaya, MR Pollak, G Yao, J Zhou Biomaterials 183, 295-305, 2018 | 13 | 2018 |
| Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes DH Vandorpe, JF Heneghan, JS Waitzman, GM McCarthy, A Blasio, ... Pflügers Archiv-European Journal of Physiology 475 (3), 323-341, 2023 | 6 | 2023 |
| Disease modeling with kidney organoids S Karp, MR Pollak, B Subramanian Micromachines 13 (9), 1384, 2022 | 5 | 2022 |
| Bio-engineered human kidney for the study of nephrotoxicity and kidney disease TM DesRochers, W Ko, B Subramanian, R Perrone, JV Shah, DL Kaplan JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE 6, 126-126, 2012 | 2 | 2012 |
Jing ZhouBrigham and Women's Hospital, Harvard Medical School在 rics.bwh.harvard.edu 的电子邮件经过验证
